Keywords: mochida, seeks, otc, switch, epadel, japan, mid-size

Mochida seeks OTC switch for Epadel

Article | 09 February 2009

Print This

Japan's mid-size drugmaker Mochida Pharmaceutical plans to switch one of its mainstay products, Epadel (ethyl icosapentate or EPA) for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in